TrialBMC cancer2019

First-line single-agent regorafenib in frail patients with metastatic colorectal cancer: a pilot phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD).

A Carrato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.